✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹24,572 Cr.
P/E
36.06

Key Ratios

Market cap
24,572 Cr
PE
36.06
Prom Holding
77.92 %
ROE (%)
16.87
ROCE (%)
21.66
Div Yield (%)
-
Sales
7,895 Cr
OPM (%)
18.67 %
Debt to Equity
0.71
About
Emcure Pharmaceuticals is a prominent Indian pharmaceutical company specializing in the develo… Read more
Low
889
52W Range
High
1580
  • Emcure Pharma
  • Eris Lifesciences
  • Pfizer

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Formulation

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Operational Metrics

US DMF Filings (.)

  • Emcure Pharmaceuticals Ltd.
Select a Metric
  • US DMF Filings (.)
  • R&D as a % of Total Sales (%)
Peer Comparison
FAQs on Emcure Pharmaceuticals Ltd. Business

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.

Emcure Pharma major competitors are Eris Lifesciences, Astrazeneca Pharma I, Onesource Specialty, JB Chem & Pharma, Pfizer, Piramal Pharma, Wockhardt.
Market Cap of Emcure Pharma is ₹24,324 Crs.
While the median market cap of its peers are ₹25,073 Crs.

Emcure Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Emcure Pharma is 4.96 and is ranked 6 out of its 8 competitors.

Company Filing
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material